Details for New Drug Application (NDA): 012546
✉ Email this page to a colleague
NDA 012546 describes TENUATE DOSPAN, which is a drug marketed by Nostrum Labs Inc and is included in one NDA. Additional details are available on the TENUATE DOSPAN profile page.
The generic ingredient in TENUATE DOSPAN is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
The generic ingredient in TENUATE DOSPAN is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
Summary for 012546
| Tradename: | TENUATE DOSPAN |
| Applicant: | Nostrum Labs Inc |
| Ingredient: | diethylpropion hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 012546
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
